Christopher Skelly, MD, is the Chief of Vascular Surgery and Endovascular Therapy at the University of Chicago Medical Center, and is a national expert in minimally invasive surgery for the treatment of Median Arcuate Ligament Syndrome (MALS). He specializes in complex aortic and mesenteric pathology as well as minimally invasive approaches to treat vascular disease. In addition to his interest in MALS, Dr. Skelly's research interests include the study of blood flow and how arteries remodel in response to stress. Dr. Skelly has authored more than 35 scientific articles in peer-reviewed journals, many pertaining to MALS, and several book chapters and reviews. He is working on numerous clinical trials involving MALS and other vascular issues, and recently edited a book for clinicians entitled Difficult Decisions in Vascular Surgery: An Evidence-based Approach. He received his medical degree from New York Medical College in 1997.